China price cuts put pressure on foreign drugmakers
New bidding systems make multinationals compete more directly with local generics
Beijing
STARTING from June 1, most drugs in China will be liberated from government-set price caps. For foreign drugmakers, though, pressure to cut prices is rising.
Since late last year, many provincial governments have introduced new bidding systems to lower the cost of medicines they procure, and they're pushing multinationals to compete more directly with cheap local generics on price.
That's forcing many overseas drugmakers to stop selling certain treatments to public hospitals in regions where prices are pushed too low, according to…
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Sony deal for Paramount would draw added regulatory scrutiny
Lululemon to shutter Washington distribution center, lay off 128 employees
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom